Prof Yves Pommier - National Cancer Institute, Bethesda, USA
Prof Pommier talks to ecancertv at TAT 2015 about the role of PARP inhibitors in targeted anticancer therapies - particularly in combination with other therapeutic agents, including DNA-targeting drugs.